NYSE:ACIConsumer Retailing
Should FDA Recall Failures in Infant Formula Oversight Require Action From Albertsons Companies (ACI) Investors?
In November 2025, the FDA issued a warning letter to Albertsons after regulators found recalled ByHeart Whole Nutrition Infant Formula linked to a multistate infant botulism outbreak still available for purchase across multiple Albertsons-affiliated stores in 11 states.
The letter highlights serious gaps in Albertsons’ recall execution and communication processes, raising questions about its food safety controls and regulatory risk management.
We’ll now examine how this FDA warning, centered...